Table 1 Baseline characteristics of the patients according to randomization groups
Characteristics | M group (n = 18) | HS group (n = 17) |
|---|---|---|
Age, years | 44 ± 14 | 46 ± 10 |
Male | 9 (50.0 %) | 9 (52.9 %) |
Body mass index | 23.3 ± 4.7 | 24.5 ± 2.5 |
Operation time, h | 5.1 ± 1.3 | 4.0 ± 1.0 |
Use of mannitol before the study | ||
Incidence | 4 (22 %) | 5 (29 %) |
Time of use before the study, h | 10.3 ± 3.3 | 12.6 ± 3.3 |
Serum biochemistry | ||
Sodium, mmol/L | 137 ± 2 | 138 ± 3 |
Potassium, mmol/L | 3.5 ± 0.3 | 3.5 ± 0.4 |
Glucose, mmol/L | 6.66 ± 1.80 | 6.83 ± 1.64 |
Triglyceride, mmol/L | 1.57 ± 0.27 | 1.64 ± 0.21 |
Cholesterase, mmol/L | 4.21 ± 0.75 | 4.32 ± 1.02 |
Albumin, g/L | 37.6 ± 3.4 | 36.8 ± 4.5 |
Globulins, g/L | 24.8 ± 3.9 | 23.7 ± 3.2 |
Total protein, g/L | 62.4 ± 6.6 | 60.5 ± 7.1 |
Blood urea nitrogen, mmol/L | 3.9 ± 1.8 | 4.0 ± 1.2 |
APACHE II | 15 ± 2 | 14 ± 3 |
Reason for use of hyperosmolar agents | ||
Treatment | 5 (28 %) | 5 (29 %) |
Prevention | 13 (72 %) | 12 (71 %) |